TheProfitWatch

ELVN - Enliven Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
20.19 1.54 (7.63%) --- --- --- --- 1.54 (7.63%) --- ---

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.57
Diluted EPS:
-0.57
Basic P/E:
-38.1228
Diluted P/E:
-38.1228
RSI(14) 1m:
63.5
VWAP:
21.73
RVol:
0.7981

Events

Period Kind Movement Occurred At
1m Price increase 1m 21.44 +0.33 (+1.56%) Oct 15 11:48

Related News